Response to COVID-19 Outbreak
Updated 02 July 2020
We are continuing to respond to the COVID-19 outbreak by adhering to these core principles.
• Maintain the health of our staff and customers
• Be responsible by helping to limit the impact of the outbreak on the wider community
• Maintain the supply of products and support to our customers
Throughout the outbreak, Cambridge Bioscience has played a role in supporting COVID-19 testing, research, vaccine, and therapeutic development. We have continued to operate throughout the UK lockdown, sourcing and supplying reagents, consumables, instruments, and services against a backdrop of major supply chain disruption and logistical challenges. It has been our pleasure to contribute in a small way to the overall effort to try to contain the outbreak.
We are now entering a new phase of greater stability and optimism in which our customers are planning and trialling their own return to work processes.
We are working hard to ensure that we are ready to support our customers, by developing our own new working practices that will ensure the smooth continued provision of products and services throughout the transition back to more normal levels of activity.
If you have any further questions, please do not hesitate to contact us at email@example.com